Gordon Carl L's Form 4 filing
Terns Pharmaceuticals, Inc. (TERN) · filed Aug 18, 2022
- Accession no.
- 0000947871-22-000910
- Filed
- Aug 18, 2022
- Trade date
- Aug 16, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 3 derivative transactions. Open-market purchases total $8.93M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gordon Carl LCIK 0001282930 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2022 | Common Stock | PPurchaseAcquired | +2,470,200 | $2.42 | +$5,977,884 | 4,744,923 | Indirect | |
| Aug 16, 2022 | Common Stock | PPurchaseAcquired | +457,400 | $2.42 | +$1,106,908 | 1,973,881 | Indirect | |
| Aug 16, 2022 | Common Stock | PPurchaseAcquired | +762,400 | $2.42 | +$1,845,008 | 762,400 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2022 | Common Stock | PPurchaseAcquired | +207,500 | – | – | 207,500 | Indirect | |
| Aug 16, 2022 | Common Stock | PPurchaseAcquired | +38,450 | – | – | 38,450 | Indirect | |
| Aug 16, 2022 | Common Stock | PPurchaseAcquired | +64,050 | – | – | 64,050 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.